Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.65 USD | +6.32% | +4.19% | -6.90% |
08/05 | Earnings Flash (CPRX) CATALYST PHARMACEUTICALS Posts Q1 EPS $0.38, vs. Street Est of $0.30 | MT |
08/05 | Catalyst Pharmaceuticals, Inc. Reaffirms Revenue Guidance for the Full-Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.90% | 1.85B | |
-2.61% | 88.47B | |
+3.82% | 40.71B | |
-13.92% | 32.43B | |
+54.25% | 24.28B | |
-15.25% | 15.52B | |
-39.93% | 12.17B | |
-11.75% | 12B | |
-14.80% | 12.01B | |
+7.57% | 8.87B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Catalyst Pharmaceuticals : Cantor Fitzgerald Adjusts Price Target on Catalyst Pharmaceuticals to $11 From $8, Maintains Overweight Rating